Readings: Galleon Wind-down, Solar, Biotech, etc.

  • Bleeding Biotech (which argues for more money for biotech, an idea I disagree with) (American)
  • Professional Money Management and Peak Oil (Gregor)
  • The market is 25% overvalued; 15% correction coming (Grantham)
  • We must overturn the status quo in derivatives (FT/Griffin)
  • Solar Projects Are Going To Need Plenty Of Water (BI)
  • Galleon Wind-Down of Funds Is ‘Largely Complete’ (WSJ)
  • Detroit real estate auction flops (Reuters)

Related posts:

  1. Mitsubishi Ups Investment in Wind Turbines
  2. Biotech Flops & Gas Stations
  3. Fixing Solar Power’s Economics, the “Easy” Way
  4. Biotech Offshoring Hits Commercial Realtors — and Politicians
  5. First Solar: The Google of Cleantech?